MMC vs VYGR · P/E 22, rev $24.46B vs rev $5.8M
Marsh & McLennan Companies Inc (MMC) versus Voyager Therapeutics Inc (VYGR) — a side-by-side from cached financials, not a winner call.
Marsh & McLennan Companies Inc (MMC) is a insurance brokers company listed on US.
Voyager Therapeutics Inc (VYGR) is a biotechnology company listed on NASDAQ.
Latest reported MMC revenue for 2024-12-31 was $24.46B. Net income was $4.12B. Revenue was up 7.6% from 2023-12-31 to 2024-12-31. MMC currently screens at market cap $89.82B and trailing P/E 21.9.
Latest reported VYGR revenue for 2026-06-30 was $5.8M. Net income was -$52.4M. VYGR currently screens at market cap $225.4M.
MMC currently screens at market cap $89.82B and trailing P/E 21.9. VYGR currently screens at market cap $225.4M.
Not investment advice. Open the MMC and VYGR stock pages for the full models.
Not investment advice.